申请人:Ortho Pharmaceutical Corporation
公开号:US04822800A1
公开(公告)日:1989-04-18
Substituted 3-isoquinolinol compounds of the general formula ##STR1## that exhibit cardiotonic, renal vasodilating and phosphodiesterase fraction III properties are pharmacologically active in the treatment of cardiac conditions. Methods for synthesizing and using those compounds are described.
具有一般式##STR1##的3-异喹啉醇化合物表现出强心、肾血管扩张和磷酸二酯酶Ⅲ活性,在治疗心脏疾病方面具有药理活性。描述了合成和使用这些化合物的方法。